Devonian Health Group Inc (GSD) - Cash Flow Conversion Efficiency

Latest as of October 2025: -0.245x

Based on the latest financial reports, Devonian Health Group Inc (GSD) has a cash flow conversion efficiency ratio of -0.245x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-2.35 Million ≈ $-1.70 Million USD) by net assets (CA$9.60 Million ≈ $6.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Devonian Health Group Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Devonian Health Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GSD total debt and obligations for a breakdown of total debt and financial obligations.

Devonian Health Group Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Devonian Health Group Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
OCB Bhd KLSE:5533	0.103x
Clean Seas Seafood Ltd AU:CSS	0.194x
Arvee Laboratories (India) Limited NSE:ARVEE	0.043x
Khadim India Limited NSE:KHADIM	0.004x
A Dong Paint JSC VN:ADP	N/A
Castor Maritime Inc NASDAQ:CTRM	0.002x
Everbright Digital Holding Limited Ordinary Shares NASDAQ:EDHL	N/A
Silverline Endustri ve Ticaret AS IS:SILVR	-0.012x

Annual Cash Flow Conversion Efficiency for Devonian Health Group Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of Devonian Health Group Inc from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Devonian Health Group Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-07-31	CA$9.14 Million ≈ $6.61 Million	CA$-1.25 Million ≈ $-902.62K	-0.137x	-133.55%
2024-07-31	CA$13.86 Million ≈ $10.03 Million	CA$5.64 Million ≈ $4.08 Million	0.407x	+233.12%
2023-07-31	CA$14.25 Million ≈ $10.31 Million	CA$-4.36 Million ≈ $-3.15 Million	-0.306x	-73.26%
2022-07-31	CA$16.27 Million ≈ $11.77 Million	CA$-2.87 Million ≈ $-2.08 Million	-0.176x	+27.58%
2021-07-31	CA$7.52 Million ≈ $5.44 Million	CA$-1.83 Million ≈ $-1.33 Million	-0.244x	-12.78%
2020-07-31	CA$9.38 Million ≈ $6.79 Million	CA$-2.03 Million ≈ $-1.47 Million	-0.216x	-88.03%
2019-07-31	CA$10.08 Million ≈ $7.29 Million	CA$-1.16 Million ≈ $-837.62K	-0.115x	+31.72%
2018-07-31	CA$12.74 Million ≈ $9.21 Million	CA$-2.14 Million ≈ $-1.55 Million	-0.168x	+43.31%
2017-07-31	CA$8.19 Million ≈ $5.92 Million	CA$-2.43 Million ≈ $-1.76 Million	-0.297x	+42.78%
2016-07-31	CA$4.13 Million ≈ $2.99 Million	CA$-2.14 Million ≈ $-1.55 Million	-0.519x	-84.91%
2015-07-31	CA$5.19 Million ≈ $3.75 Million	CA$-1.46 Million ≈ $-1.05 Million	-0.281x	--

About Devonian Health Group Inc

V:GSD Canada Biotechnology

Market Cap

$20.01 Million

CA$27.66 Million CAD

Market Cap Rank

#25034 Global

#982 in Canada

Share Price

CA$10.00

Change (1 day)

-15.97%

52-Week Range

CA$0.11 - CA$14.00

All Time High

CA$14.00